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ABSTRACT 
 
Sarath Vijayakumar. THE ROLE OF MEDIATORS OF NEURONAL PLASTICITY IN 
THE CIRCADIAN REGULATION OF SUPRACHIASMATIC NUCLEUS BY LIGHT. 
(Under the direction of Dr. Jian Ding) Department of Physiology, August 27, 2009. 
 
Circadian rhythms are highly conserved physiological functions that are present in almost all 
living organisms. In mammals, circadian rhythms are synchronized to the environmental 
light:dark cycle by daily adjustments in the hypothalamic suprachiasmatic nucleus (SCN), the 
location of the master circadian pacemaker. We hypothesize that light entrainment of the 
circadian clock involves neural plastic adaptations in the SCN. The mechanism of neural 
plasticity has been intensively studied in the hippocampus and the dentate gyrus.  However, the 
cell and molecular mechanism underlying circadian clock resetting in the SCN remains poorly 
understood.  Thus, we sought to investigate whether modulators that are known to regulate 
neural plasticity in the hippocampus play a role in the signal transduction of circadian clock 
resetting. Light induced expression of tissue-type plasminogen activator (tPA) in the SCN, 
maximal induction was seen one hour following a light pulse at circadian time (CT) 16. A 
corresponding increase in the tPA proteolytic activity was also observed. tPA-STOP™ (an 
inhibitor of tPA)-infused animals exhibited attenuated light-induced phase delay of circadian 
wheel running activity. The levels of  cyclin-dependent kinase 5 activators, p35 and p25 were 
decreased at Zeitgeber Time (ZT) 16, at ZT22 the levels were increased whereas, no change was 
observed at ZT6. The bi-transgenic animal, CK-p25 demonstrated increased phase delay at CT16 
and attenuated phase advance at CT22 following transient overexpression of p25.  SCN neurons 
expressing p25 co-localized with phosphorylated-extracellular signal-regulated kinase and 
Gastrin Releasing Peptide. This is one of the first studies to report the involvement of these 
neuromodulators in circadian light entrainment. Mounting evidence shows that circadian rhythm 
disturbances may be associated with increased health risks, such as jet-lag, cancer development, 
cardiovascular and metabolic disorders. The findings of this study have improved our 
understanding of the complex and intricate pathways involved in light entrainment and may lead 
to development of novel therapeutic avenues in treating circadian rhythm disturbances. 
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CHAPTER 1 – INTRODUCTION 
 
“Mechanism is not the biologist’s only business. He is, or should be, concerned also with 
questions of both function and history” – Colin Pittendrigh (1966) 
 
Circadian Rhythms 
 
Most organisms live in an environment that is changing continuously in a 
rhythmic manner based on Earth’s rotation around its axis. Organisms exhibit daily 
changes in physiology and behavior based on this astronomical phenomenon (Hastings et 
al., 2003; Pittendrigh, 1993). These daily changes that occur with a period of around 24 
hr are termed circadian from Latin “circa diem” meaning “about a day”. Circadian 
rhythms have evolved in most species, ranging from single cell organisms to plants and 
animals. The cyanobacterium Synechococcus, shows circadian rhythmicity in its 
photosynthetic machinery (Dunlap et al., 2004; Harmer et al., 2001), while the 
dinoflagellate Lingulodinium shows bioluminescent rhythmicity (Dunlap et al., 2004; 
Lowrey and Takahashi, 2004). In mammals, circadian rhythmicity is seen in the sleep-
wake cycle, cardiovascular activity, hormonal secretions, body temperature, hepatic 
metabolism, gastro-intestinal physiology and many other metabolic and behavioral 
processes. Circadian rhythms persist with intrinsic periods close to 24 hr even in the 
absence of any external time cues, indicating the presence of an internal time keeping 
system or “circadian clock” in every organism. Circadian rhythms expressed in the 
absence of external cues are defined as “free-running”. The “free-running” rhythms often 
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deviate from 24 hr and need to be adjusted to the environment by external signals, called 
Zeitgebers. This adjustment process is called entrainment. The most potent Zeitgeber for 
animals is the environmental light-dark cycle. 
The “circadian clock” has undergone evolutionary changes becoming more 
complex in higher species (Herzog, 2007). In the marine snail, Bulla gouldiana, 
approximately 100 basal retinal neurons in the eye  act as the circadian pacemaker 
coordinating its daily locomotor activity (Block and Wallace, 1982). In the fruit fly, 
Drosophila melanogaster, a group of neurons located in the lateral and dorsal brain 
drives rhythms in locomotion, photophobicity and eclosion (Helfrich-Forster, 2005; 
Stoleru et al., 2004). In birds, for instance, the sparrow, extra-retinal photoreceptors 
within the brain acts as the “circadian clock” (Menaker, 1968). 
The Suprachiasmatic Nucleus 
 
In mammals, the master circadian pacemaker is located in the hypothalamic 
suprachiasmatic nucleus (SCN). Surgical ablation of the SCN results in a loss of 
circadian rhythms of locomotor activity, drinking behavior and corticosterone release 
(Moore and Eichler, 1972; Stephan and Zucker, 1972a, b). Allograft transplant of fetal 
SCN tissue to SCN-lesioned hosts was able to restore their locomotor activity (Lehman et 
al., 1987). When fetal SCN taken from mutant hamsters with a 20 hour period was 
transplanted to SCN-lesioned wild type host with 24 hour period, the restored rhythm of 
the wild type host became 20 hour circadian period.  These studies suggest that the SCN 
is the master circadian pacemaker that determines the overall circadian rhythm of the 
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animal (Ralph et al., 1990). All these experiments clearly demonstrate the importance of 
the SCN in orchestrating circadian rhythms. 
SCN Input and Output Pathways 
 
The SCN is a paired nucleus consisting of approximately 10,000 neurons each 
and is located on either side of the third ventricle above the optic chiasm in the 
hypothalamus (Abrahamson and Moore, 2001; Van den Pol, 1980). The SCN receives 
input from many brain regions (Fig. 1). The main input is via the retino-hypothalamic 
tract (RHT), a monosynaptic pathway originating from an unique set of non-image 
forming retinal ganglions cells (RGCs) that express the photopigment melanopsin and are 
intrinsically photo sensitive (Berson et al., 2002; Johnson et al., 1988; Moore and Lenn, 
1972). Glutamate (Glu) and the neuropeptide Pituitary Adenylyl Cyclase Activating 
Peptide (PACAP) are the principal neurotransmitters released from the RHT terminals to 
the SCN (Ebling, 1996; Hannibal, 2002; Hannibal et al., 1997). SCN also receives non 
photic input via the geniculo-hypothalamic tract that projects from the intergeniculate 
leaflet (IGL) carrying neuropeptide Y, and projections from the mesencephalic raphé 
nuclei that are serotonergic. These pathways project mainly to the ventral SCN (Moga 
and Moore, 1997; Moore and Card, 1990; van Esseveldt et al., 2000). The dorsal SCN 
receives input mainly from the basal forebrain and infralimbic cortex (Moga and Moore, 
1997). There are several other minor pathways that project to the SCN from the 
hypothalamic tuberomammillary, arcuate and supraoptic nuclei (Krout et al., 2002; Morin 
and Blanchard, 2001; Saeb-Parsy et al., 2000). 
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The SCN has three major output pathways (Fig. 1). The pathway that contains the 
largest portion of SCN efferents runs in an arc dorsally and caudally. This pathway  
projects to regions surrounding the SCN, mainly the paraventricular nucleus, the 
subparaventricular zone, and the dorsomedial hypothalamus (Leak et al., 1999). The 
other two pathways are to the medial preoptic area and to the retrochiasmatic area and the 
capsule of the ventromedial nucleus. Additionally, the SCN has sparse projections to 
other brain areas, i.e., the tuberomammillary nucleus, the ventrolateral preoptic nucleus, 
and an indirect projection to the limbic system via the paraventricular nucleus 
(Abrahamson et al., 2001; Chou et al., 2002; Peng and Bentivoglio, 2004). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5 
 
  
Figure 1: SCN input and output pathways. 
 
 
The diagram depicts the major input and output pathways to and from the SCN. The 
ventral SCN containing VIP neurons and the dorsal SCN containing AVP neurons are 
outlined. DMH (dorsomedial hypothalamus), PVN (paraventricular nucleus), sPVZ (sub 
paraventricular zone), RHT (retino-hypothalamic tract), 3V (third ventricle), OC (optic 
chiasm), GHT (geniculo-hypothalamic tract). The inputs and outputs are shown on 
separate sides for clarity.   
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Molecular Basis of the Mammalian Circadian Clock 
 
At the molecular level, the circadian clock involves a cell-autonomous 
transcription-translation feedback loop comprising a core set of  “clock genes” (Lowrey 
and Takahashi, 2004). In mammals, circadian locomotor output cycles kaput (Clock) and 
its paralogue neuronal Period-Aryl hydrocarbon nuclear translocator-Single-minded 
(PAS) domain protein 2 (Npas2), Brain and muscle aryl hydrocarbon receptor  nuclear 
translocator-like (Bmal1), period homologue 1, 2 (Per1, Per2), and Cryptochrome 1, 2 
(Cry1, Cry2) form the primary negative-feedback loop (Fig. 2). During the day, the basic 
helix-loop-helix transcription factors CLOCK and BMAL1 activate transcription of the 
Per and Cry genes. The PER and CRY proteins heterodimerize, translocate to the nucleus 
and inhibit their own transcription (Lee et al., 2001). During the night, the PER-CRY 
repressor complex is degraded and a new transcription cycle is initiated by CLOCK-
BMAL1. The entire transcription-translation loop takes approximately 24 hours to 
complete. In addition to the primary feedback loop, there is a secondary negative-
feedback loop formed by the nuclear hormone receptor, Rev-erba, a direct repressor of 
Bmal1 transcription. Further stabilization of the primary feedback loop is brought about 
by auxiliary loops involving the orphan nuclear receptor, RORα, and other clock 
components Dec1 and Dec2 (Ko and Takahashi, 2006; Ueda et al., 2002). 
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Figure 2: Simplified model of the mammalian molecular clock (Gachon et al., 2004). 
 
Two interlocking positive and negative loops form the core of the molecular oscillator. 
During the day, BMAL1 forms a heterodimeric complex with CLOCK that acts via E-
BOX DNA regulatory sequences to drive the expression of Period (Per1, per2) and 
Cryptochrome (Cry1 and Cry2) genes. PER:CRY complex accumulate during the night 
translocate to the nucleus and inhibit their own transcription, thus forming the negative 
loop. Once the PER:CRY complex level goes down after degradation, a new cycle starts 
all over again. CLOCK and BMAL1 also drive expression of Rev-Erbα, which in turn 
competes for binding elements on the Bmal1 promotor, acting to stabilize the loop. 
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Modified from Gachon et al., 2004 
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Circadian Clock Resetting By Light – Photic Entrainment 
 
Photic entrainment of circadian rhythms occurs through daily, light-induced 
adjustments in the phase and period of the SCN pacemaker (Daan, 1976; Decoursey, 
1964). In mammals, the photic entrainment process has been characterized mainly by 
studying the resetting effects of brief light exposure in nocturnal rodents. In experimental 
animals housed under programmed lighting schedule, the Zeitgeber time (ZT) is defined 
relative to the experimental light:dark (L:D) cycle. By definition, ZT0 is the time when 
the lights are on and ZT12 is the time when lights are off in the animal housing. When 
the animals are kept in constant conditions (usually constant darkness), they start to “free-
run”. This “free running” rhythm often deviates from 24 hr and shows inter-species 
variation. Under “free-running” conditions, time scale is expressed in Circadian time 
(CT) units (Daan, 1976). One circadian cycle is divided into 24 equally sized circadian 
units, one unit being defined as the division of the intrinsic “free-running” period (τ) by 
24. CT0 is defined as the beginning of the subjective day (the onset of the rest phase in 
nocturnal rodents) and C12 as the beginning of the subjective night (the onset of the 
activity phase in nocturnal rodents). Under constant darkness (DD), brief light exposure 
during the early subjective night causes phase delays, while exposure during the late 
subjective night causes phase advances of the SCN circadian clock. Light exposure 
during the subjective day elicits either very minimal phase shift or none at all. The “phase 
dependence” of the response of the SCN circadian clock to light is depicted in the photic 
phase response curve (PRC; Fig. 3B) (Daan, 1976; De Coursey, 1960). The quantitative 
aspects of the photic PRC: the relative amplitude and duration of the phase delay and 
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advance regions of the PRC curve vary widely among species (Fig. 4) and is also 
influenced by the photoperiod (Rusak and Zucker, 1979; Travnickova et al., 1996). 
Typically, animals with intrinsic period τ less than 24 hr show large amplitude phase 
delays and smaller phase advances. Conversely, animals with τ greater than 24 hr show 
large phase advances and smaller phase delays. 
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Figure 3: Photic phase response curves and their derivation (Dunlap et al., 2004). 
 
(A)  Light pulse is applied to free-running animal at different circadian phase points to 
derive the phase response curve. The horizontal lines in A-E, represent the daily activity 
of the animal maintained in constant darkness over a 15 day period. On day zero, the 
animals are briefly exposed to light (square, “light pulse”). The time difference between 
the dotted line extrapolating the trajectory of the animal’s activity prior to the light pulse 
and the actual onset of activity after the light pulse is known as a phase shift. 
(B)  Phase response curve for the animal in A. The sinusoidal phase shift curve plotted, as 
a function of circadian time, is known as the PRC. Point A represents a time of the 
animal’s subjective day during the light-insensitive period and is referred to as the “dead 
zone”. Points C and D are examples of a phase delay and advance, respectively.  
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Dunlap et al., 2004 
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Figure 4: Species difference in photic phase response curve (Hannibal et al., 2002). 
 
Depiction of complete photic phase response curve of three different species, mouse, rat, 
and hamster. Phase delays are plotted in negative direction and phase advances in the 
positive direction. The horizontal axis represents 24 hr period. Typically, animals with 
intrinsic period τ less than 24 hr show large amplitude phase delays and smaller phase 
advances. On the other hand, animals with τ greater than 24 hr show large phase 
advances and smaller phase delays. Mouse with τ less than 24 hr shows a greater 
amplitude phase delay and a small amplitude phase advance. Hamster with τ more than 
24 hr shows a greater phase advance than phase delay. τ (tau/ “free-running” period) 1, 2 
and 3 represent subjective day, subjective early night and subjective late night 
respectively.  
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Mechanism of Photic Resetting of the Circadian Clock 
 
Although the phenomenon of photic resetting was discovered in 1960 (De 
Coursey, 1960), the exact mechanism responsible for the phase dependent photic 
response of the SCN circadian clock remains elusive. Considerable research done in the 
last nearly 50 years has improved understanding of this phenomenon. Several signal 
transduction pathways have been proposed (Fig. 5), including the phosphorylation of 
transcription factor CREB (Gau et al., 2002; Ginty et al., 1993), the activation of cGMP 
and Ca2+/calmodulin kinase II (CaMKII) (Gillette, 1996; Ginty et al., 1993; Mathur et al., 
1996; Tischkau et al., 2003a; Tischkau et al., 2003b). Several other kinases, including 
mitogen-activated kinase (MAPK) (Akashi et al., 2008; Akashi and Nishida, 2000; Cao et 
al., 2008; Dziema et al., 2003; Obrietan et al., 1998) and Ca2+/calmodulin kinase (CaMK) 
(Wu et al., 2001) have also been implicated in the activation of CREB in the SCN. 
Upon photic stimulation, Glu is released in the RHT initiating a series of signal 
transduction cascades in the SCN that ultimately result in a phase shift of the circadian 
clock (Ding et al., 1994; Golombek et al., 2003). Glutamate released from the RHT 
activates N-methyl-D-aspartate (NMDA), non-NMDA (AMPA/kinate) and metabotropic 
(mGluR1) receptors in the SCN (Ebling, 1996). Glutamate also induces an increase in 
intracellular Ca2+  levels in the SCN (Colwell, 2001; van den Pol et al., 1992). Although 
currents evoked by exogenous application of AMPA did not show a diurnal rhythm in 
their magnitude, there was daily rhythm in the magnitude of AMPA-induced Ca2+  
transients that peaked during the night (Michel et al., 2002).  
The increased intracellular Ca2+  results in the activation of a plethora of enzymes 
in the SCN, particularly, CamKII and neuronal nitric oxide synthase (nNOS). Activation  
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Figure 5: Putative photic signal transduction pathway in the SCN. 
 
Glutamate activation of NMDA receptors in the SCN results in calcium influx that 
activates NOS and CaMK activity, which in turn modulates other kinases such as PKG 
and MAPK which lead to the phosphorylation of CREB and induction of clock genes 
producing phase shifts of the clock. PACAP stimulation activates several signaling 
pathways via cAMP/PKA and or MAPK pathways. (NOS- Nitric oxide synthase, NO-
Nitric Oxide, GC- Guanylyl cyclase, cGMP-cyclic GMP, PKG-Protein kinase G, CREB-
cAMP response element binding protein, RyR-ryanodine receptor, AC-Adenylyl Cyclase  
cAMP-cyclic AMP, PKA-Protein kinase A, CaMKII- calmodulin-dependent kinase II. 
See text for details). 
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of nNOS leads to the formation of nitric oxide (NO). Several studies have indicated the 
role of nNOS in circadian photic resetting (Agostino et al., 2004; Ding et al., 1994; 
Ferreyra et al., 1998; Melo et al., 1997; Watanabe et al., 1994). The pathway downstream 
of NO diverges and is thought to be responsible for inducing the bi-directional phase 
shifts during the night. During the late night, NO activates soluble guanylyl cyclase 
inducing changes in both cGMP levels and cGMP-dependent protein kinase activity 
(cGK) (Taishi et al., 2001; Tischkau et al., 2003b). Mechanisms downstream of cGK 
activation are not completely elucidated but, acting through intermediary pathways cGK 
activation culminates in phosphorylation of CREB and induction of PER protein 
expression. During early night, there occurs additional mobilization of Ca2+ from 
intracellular stores via the activation of ryanodine receptors (Ding et al., 1998). Recently, 
Pfeffer et al. showed that dysfunctional ryanodine calcium signaling in the BMAL1 null 
mutant led to an impaired light-input pathway selectively during early night (Pfeffer et 
al., 2009). Photic stimulation also releases the neurotransmitter PACAP in the RHT 
(Hannibal et al., 2000; Liu and Madsen, 1997; Yaka et al., 2002). Multiple signaling 
pathways are involved in the PACAP-mediated light entrainment of the SCN. Activation 
of the PACAP receptors by light stimulates the cAMP/PKA signaling pathway resulting 
in CREB phosphorylation events and phase advance of the clock (Chen et al., 1999; 
Tischkau et al., 2000). It also modulates gluatamatergic signaling via the ERK/MAPK 
pathway. NMDA receptor activation also involves CaMKII mediated ERK/MAPK 
pathway. MAPK stimulation activates the phosphorylation of CREB which results in the 
induction of clock genes (Butcher et al., 2002; Coogan and Piggins, 2003; Dziema et al., 
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2003; Obrietan et al., 1998). The exact downstream targets that induce phase delay during 
early night remain largely unknown. 
Neuronal Plasticity in Circadian Photic Resetting 
 
Circadian rhythms have three defining characteristics: 1) The rhythms are 
persistent in constant conditions independent of environmental time cues. 2) The rhythms 
show temperature compensation, the “free-running” period of the organism remains 
constant over a wide-range of ambient temperatures. 3) The most important feature of 
circadian rhythms is their ability to be entrained by cycling environmental  time cues or 
Zeitgebers. Light is the major environment cue that can reset the circadian clock. The 
ability of light to reset the clock allows it to maintain temporal alignment with external 
time cues. A short light pulse given during the sensitive circadian phase can permanently 
reset the phase of the circadian clock over a period of few days. Light-induced resetting 
of the circadian clock is a classic example of short-term environmental stimuli inducing 
long-lasting behavioral adaptations. 
Long-term potentiation (LTP), long lasting activity-dependent increase in the size 
of a synaptic response, was first described by Bliss and Lømo (Bliss and Lomo, 1973). It 
is now considered to be the cellular mechanism underlying learning and memory. LTP 
has been divided into an early phase LTP (E-LTP) that lasts for 1-2 hr and involves 
modifications of pre-existing synapses as a result of increased Ca2+ flux through NMDA 
receptors and accompanying protein phosphorylation events (Bliss and Collingridge, 
1993; Malenka and Nicoll, 1999) and a late-phase LTP (L-LTP) that can last as long as 6-
8 hrs (Frey et al., 1988). L-LTP requires activation of cAMP-dependent protein kinase 
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and the transcription factor CREB (Kandel, 2001). It is also dependent on new protein 
synthesis (Fales et al., 1919; Frey et al., 1988).  Tetanic stimulation of the hippocampus 
that induces L-LTP has been shown to enhance the expression of several proteins 
(Matsuo et al., 2000; Qian et al., 1993). 
Although the exact protein synthesis responsible for the induction and 
maintenance of L-LTP remains elusive, a few have emerged as the likely candidates, 
notable among these being: brain-derived neurotrophic factor (BDNF), tissue-type 
Plasminogen Activator (tPA), Calpain and Cyclin-dependent kinase 5 (Cdk5). BDNF has 
emerged as a critical secretory protein that regulates synaptic development and plasticity 
in the CNS (Lu, 2003; Poo, 2001). tPA is another target gene being considered. Seizure, 
kindling and paradigms that induce L-LTP all cause an enhancement of tPA mRNA 
expression in the hippocampus (Qian et al., 1993). tPA mutant mice have been shown to 
exhibit a selective impairment in L-LTP (Calabresi et al., 2000; Frey et al., 1996; Huang 
et al., 1996). Calpain, a Ca2+ dependent cysteine protease has also been implicated in L-
LTP process. Calcium influx following titanic stimulation activates calpain that in turn 
cleaves fodrin, allowing translocation of Glu receptors (Lynch and Baudry, 1984). 
Several other mechanisms have also been suggested including the degradation of Glu 
receptor-interacting protein (GRIP) (Lu et al., 2001). Cdk5 is a proline-directed 
serine/threonine kinase that has been implicated in various neuronal functions, including 
learning, memory and neurodegenerative disorders (Dhavan and Tsai, 2001). A transient 
increase in Cdk5 activity was shown to enhance LTP, whereas, a prolonged hyperactivity 
resulted in learning and memory deficit (Fischer et al., 2005). 
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The role of the neurotrophin, BDNF has been extensively studied in the past 
decade. BDNF and its cognate receptor, tyrosine receptor kinase B (TrkB) are expressed 
in the SCN (Allen and Earnest, 2005; Liang et al., 1998a). Not only is BDNF expressed 
in SCN, the expression also exhibits a circadian rhythmicity with peak protein levels 
occurring at night (Liang et al., 1998b). BDNF can also reset the circadian rhythm of 
SCN neuronal activity in brain slice preparation by modulating NMDA and AMPA 
currents in the SCN neurons (Michel et al., 2006). Little is known about the potential role 
in the SCN and circadian resetting of other neuromodulators of plasticity. Drawing 
similarities in the function of the hippocampus and the SCN, it is reasonable to assume 
that the neuromodulators implicated in the neuronal plasticity in the hippocampus might 
play a similar role in the SCN.   
Objective of Current Study 
 
The main objective of this study is to investigate the role of modulators of 
neuronal plasticity in resetting the circadian clock. To achieve this objective, the 
following specific aims are devised: 
1) Investigate the role of extracellular serine protease tPA in the modulation of  
circadian clock resetting. 
2) Investigate the role of Cdk5 and its activators in circadian clock resetting. 
3) Investigate the role of cysteine protease, calpain in the photic resetting of the 
circadian clock. 
 
 
 
 
  
 
CHAPTER 2 – METHODS 
 
Animals 
 
All animal treatments conformed to the standards in the National Institutes of Health 
Guide for the Care and Use of Laboratory Animals and were approved by the East 
Carolina University Institutional Animal Care and Use Committee. 
C57BL/6: Adult male mice, 6-8 weeks of age were purchased from either The Jackson 
Laboratory (Bar Harbor, ME; Stock No. 000664) or from Harlan Laboratories 
(Indianapolis, IN). Mice were housed under standard conditions with a 12:12 hr 
Light:Dark cycle (Lights On – 7:30 AM, Lights Off- 7:30 PM) with free access to food 
and water ad libitum. Transgenic Mice: Breeding pairs of C57BL/6-Tg(tetO-
CDK5R1/GFP)337Lht/J (Stock No: 005706) and B6.Cg-Tg(Camk2a-tTA)1Mmay/DboJ 
(Stock No: 007004) were obtained from The Jackson Laboratory (Bar Harbor, ME). All 
mice were conceived and raised on a doxycycline containing diet (1mg/g, Bio-Serv, 
Frenchtown, NJ) to keep the transgene repressed. The animals were switched to a normal 
diet for 2 weeks to induce the expression of the transgene. All transgenic transgenes were 
heterozygous. Wild type littermates were used as controls. The bi-transgenic mice will be 
referred to as CK-p25. In the inducible CK-p25 mice, the expression of green fluorescent 
protein (GFP) tagged p25 is mediated by the CaMKIIα promoter regulated tet-off system. 
p25 expression is repressed in the presence of tetracycline analog, doxycyline. Robust 
p25 expression and elevated hippocampal Cdk5 activity is observed after 1-2 weeks of 
induction (Fischer et al., 2005).  A schematic of the tetracycline-inducible p25 transgene 
is given in Fig. 6.   
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Genotyping 
 
Routine genotyping of transgenic mice offspring was done from tail snips using 
REDExtract-N-Amp Tissue PCR Kit (Sigma, St. Louis, MO). DNA extraction was done 
by incubating the tail snips in a 4:1 mixture of extraction solution and tissue preparation 
solution from the kit first at 55°C for 10 min and then at 95°C for 3 min. 100 µl of 
neutralization solution B was added to sample and mixed by gentle vortexing. The 
neutralized tissue extract was immediately used for PCR reaction. The PCR reaction 
sample contained 10 µl of REDExtract-N-Amp PCR reaction mix, 4 µl of tissue extract, 
2 µl of forward and reverse primers (final concentration of 0.1M) and 2 µl of PCR grade 
water. PCR was performed on tail genomic DNA for 35 cycles of 95°C at 1 min, 55°C at 
1 min, and 72°C at 1 min on Eppendorf MasterCycler gradient (Eppendorf, Westbury, 
NY). The following PCR primers were used: 5'-AAGTTCATCTGCACCACCG-3', 
5'- TCCTTGAAGAAGATGGTGCG-3' forward and reverse primers for p25-GFP 
transgene and 5′-GTGATTAACAGCGCATTAGAGC-3′ and 5′-
GAAGGCTGGCTCTGACCTTGGTG-3′ as forward and reverse primers for CAMKII-
tTA transgene. 15 µl of the PCR reaction product was loaded on 2.5% agarose gel, 
electrophoresis was done at 75 V for 40 min. The bands on gel were visualized using 
Alpha Imager (Alpha Innotech, San Leandro, CA). 
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Figure 6: Schematic of tetracycline-inducible p25 transgene. 
 
The bi-transgenic mice (CK-p25) contains two trangenes: GFP tagged p25 and CaMKIIα-
tTA, tetracycline regulated promoter. In the absence of tetracycline, CK-p25 mice 
express p25 in a tissue specific manner. The transgene is switched on and off by 
switching the diet between normal rodent chow and a doxycycline based diet. (tTA- 
tetracycline transactivator, IRES – internal ribosome entry site, Dox- doxycycline, GFP – 
green fluorescent protein). 
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Western blotting 
 
On the day of the experiment, mice, having been entrained to a 12 hour L:D cycle 
for 10 days, were given a light pulse (~ 100 lux) starting at Zeitgeber Time (ZT) 16. At 20 
minute intervals, animals were deeply anesthetized (ketamine/xylazine, 18/2 mg/kg, i.p) 
and decapitated with a guillotine. Control animals received no light pulse and their SCNs 
were collected under dim red-light (less than 5 lux). The brain was dissected out and 
SCN-containing coronal hypothalamic brain sections (500 µm) were prepared using a 
customized tissue slicer. The sections were immediately frozen on to a glass slide over dry 
ice.  A stainless steel needle (400 µm inner diameter) was then used to punch out both SCN 
from each brain section. For each experimental condition, SCNs from 4 animals were 
collected, pooled and stored at -80°C until use.  SCN tissues were homogenized in a small 
volume of modified radio immunoprecipitation assay buffer (50 mM  Tris-HCl pH 7.4, 
1% NP-40, 0.25% Na-deoxycholate, 150 mM NaCl, 1 mM EDTA, 1 mM  PMSF, 1 
µg/ml each Aprotinin, Leupeptin, Pepstatin, 1 mM Na3VO4, and 1 mM NaF) centrifuged 
at 8000 x g for 10min at 4°C, then the supernatant was collected and stored at -80° C until 
the extracts were processed for Western blotting. Total  protein content in the lysate was 
quantified using a Bio-Rad DC protein assay kit following the manufacturer’s protocol. 50 
µg of protein lysate was loaded onto  4-12 % bis tris gel, subjected to electrophoresis and 
transblotted onto PVDF membrane. After transfer, membranes were washed with 0.5 %  
TBST, blocked with 5% powdered non-fat dry milk in TBST and then incubated overnight 
at 4oC with the primary antibody, rabbit polyclonal anti-tPA (1:1000). After incubation 
with primary antibody, membranes were washed with TBST and incubated with  
horseradish peroxidase-conjugated anti-rabbit secondary (1:5000). The ECL Plus detection 
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system (Amersham BioSciences) was used for visualization of the signal. Blots were 
quantified using UNSCAN-IT quantitative densitometry analysis software (Silk 
Corporation, USA).  
Behavioral Experiments 
 
Wheel Running Activity for tPA Study 
 
Male mice (8-10 weeks old), were anesthetized (ketamine/xylazine, 18/2 mg/kg, i.p.) and 
stereotaxically implanted with a guide cannuli (Plastic One, 22-gauge with 28-gauge 
stylet, the stereotaxic co-ordinates were AP 0.4 mm, LM 0.0 mm, DV 4.5 mm). Post-
cannulation, mice were individually housed in polypropylene cages equipped with 4 ½ -
inch running wheels for at least 10 days in 12 hour L:D cycle to recover before being put 
into constant darkness cycle (DD). Wheel running activity was monitored with Vital 
View 3.11 data acquisition software (Minimitter, Sunriver, OR) in 5- minute bins on an 
Intel Pentium computer. The injection times (CT16, CT22) were calculated for free 
running animals by adding 4 hours to the calculated CT12 time derived from a regression 
fit line of onset of activity, considering 7 days prior to the treatment day. The inhibitor, 
tPA-STOP™ (200 μM) or saline was injected into the third ventricle of restrained mice 
over a period of 2 minutes by removing the stylet and inserting a 28-gauge injector 
attached to a microsyringe. The procedure was performed in the dark with the aid of 
infrared night-vision goggles (Night Owl, CA).  After 10 days in DD following the first 
injection, the animals were given a second injection, this time the treatment was reversed, 
mice that received a first injection of tPA-STOP™ were injected with saline the second 
time and vice versa.  Raw phase-shifts were calculated as the difference between two 
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regression fit lines of activity onsets considering 7 days prior to the treatment and 7 days 
after the treatment (avoiding the first two days following treatment).  Raw phase-shifts 
were converted to circadian hours by multiplying with the factor, τ/24, where τ is the 
calculated free-running period of the particular animal. 
Wheel Running Activity for Cdk5 Study 
 
Adult CK-p25 transgenic mice and their wild type littermates 6-8 weeks old were 
transferred to light proof chambers, individually housed in polypropylene cages equipped 
with 4 ½ -inch running wheels for at least 10 days in 12:12 hr L:D cycle before being put 
into constant darkness cycle (DD). The transgene was turned on and off by switching the 
doxycycline diet (1g/kg, Bio-Serv, Frenchtown, NJ) to normal diet. The time line for the 
experiment is given in Fig. 7. 
Wheel running activity was monitored with ClockLab data acquisition software 
(Actimetrics, Wilmette. IL) in 6- minute bins on an Intel Pentium IV computer. “Free-
running” mice were exposed to a 20 min, 100-lux light pulse at one of the following 
circadian time points: CT12, CT22, CT6. At the appropriate CT, the mouse was taken out 
of the light-proof chamber in complete darkness with the aid of night vision goggles. The 
mouse was transferred to the light exposure chamber which had lights adjusted to provide 
~100 lux at cage level. After light exposure, the mouse was transferred back to the light-
proof chamber. Animals were allowed to “free-run” for 10 days between the light pulse 
treatments. Raw phase-shifts were calculated as the difference between two regression fit 
lines of activity onsets considering 7 days prior to the treatment and 7 days after the 
treatment (avoiding the first two days following treatment).  Raw phase-shifts were 
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converted to circadian hours by multiplying with the factor, τ/24, where τ is the 
calculated free-running period of the particular animal.  
Immunohistochemistry 
Under deep anesthesia with ketamine/xylazine (0.1 ml/10g body weight; 
(18mg/2mg)per kg i.p), mice were perfused transcardially with 40 ml of ice-cold 
phosphate buffered saline (PBS) pH 7.4 followed by 40 ml of 4% paraformaldehyde 
fixative. The brain was dissected out and post-fixed in the same fixative for 24 hr at 4°C. 
Coronal sections were cut using a vibratome (Vibratome 1000 Plus, St. Louis, MO) at a 
thickness of 30µm. The sections were washed with PBS for 10 min. After the wash, the 
sections were blocked with 5% Normal Horse Serum (NHS) in PBS containing 0.3% 
Triton X-100 (PBST) for 1 hour. Following blocking the sections were incubated in 
primary antibody in PBST containing 1% NHS overnight at 4°C. After incubation with 
primary antibody, the sections were washed with PBS for 3x10 min. The sections were 
then incubated with Anti-Rabbit ImmPRESS™ reagent (Vector Laboratories, 
Burlingame, CA) for 1 hour at 22°C. Next, the sections were washed with PBST for 3x10 
min. For visualization, the sections were treated with 3, 3’-diaminobenzidine (DAB) 
substrate and 0.03% hydrogen peroxide. Once the desired staining intensity has 
developed (4-7 min), the reaction was stopped by transferring the solution to PBS. The 
sections were then mounted on Superfrost Plus microscopic slides (Fisher Scientific, 
Pittsburgh, PA) and allowed to dry overnight. Sections were cleared in CitriSolv (Fisher 
Scientific, Pittsburgh, PA) 2x10 min each and coverslipped with DPX Mountant (Sigma-
Aldrich, St. Louis, MO). Images were captured using Olympus DP20 digital camera on 
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an Olympus BX51 microscope (Olympus America, Center Valley, PA). Negative control 
(no primary antibody) was included in the staining procedure to validate the specificity of 
staining. List of primary antibodies used is given in Table 1. 
Immunofluorescence  
Immunofluorescence staining was done in the same way as described under 
immunohistochemistry. The only difference was fluorescent labeled secondary antibodies 
were used. Confocal microscopy was done using Zeiss LSM510 confocal microscope. 
Electron Microscopy 
Brains from transgenic animals with and without the induction of the transgene 
were collected as described under immunohistochemistry method. They were postfixed in 
2% glutaraldehyde fixative for 2 hrs, trimmed to 10 mm2 cube containing the SCN using 
a sharp scalpel and further postfixed in 4% paraformaldehyde fixative for 24 hr at 4°C. 
The cubes were trimmed further to 5 mm2 cubes, washed in 0.1M cacodylate buffer 3 
times 10 min each. After the wash they were fixed in 1% osmium tetraoxide for 1 hr 
rinsed with 0.1 M phosphate buffer for 10 min and stained en-block with 1% uranyl 
acetate. The SCN cubes were then dehydrated in graded series of ethanol (25, 50, 75, 95, 
100 and 100%) for 15 min each.  Embedding was done in increasing concentrations of 
Spurr’s media in ethanol – 30% for 30 min, 70% for 1 hr, 100% for 2 hr, 100% for 30 
min and finally in 100% media in a flat tissue tear-away container.  The block was 
trimmed to 2 mm2 cube and ultrathin silver-gray sections (80nm) were cut using Leica 
EM UC6 ultramicrotome (Leica, Germany), collected on 200 mesh copper grids. 
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Table 1: Primary antibodies used for immunohistochemistry, immunofluoresece 
and Western blotting. 
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Primary Antibody Concentration 
tPA 
(American Diagnostica) 
1:500 
Cdk5 (C-18) 
(Santacruz Biotechnology) 
1:500 
P35 (C-19) 
(Santacruz Biotechnology) 
1:500 
Calpain-1 (domain IV) 
(Abcam) 
1:1000 
p-ERK (anti-phospho42/44 MAPK) 
(Cell Signaling Technology) 
1:400 
GRP (FL-148) 
(Santacruz Biotechnology) 
1:500 
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Sections were viewed with a  JEOL 1200 EX electron microscope (Japan Electron Optics 
Laboratory Co., Japan) operated at 60 kV accelerating voltage. Images were captured 
using a SIS MegaView III CCD camera.  Synaptic counting was done as described by 
(Knott et al., 2002). Briefly, serial electron micrographs were arranged in sequence and 
sampling rectangle was drawn on each micrograph. Synapses were counted within this 
sample rectangle. A synapse was identified as a region of  synaptic density with at least 3 
identifiable vesicles. Synapses that crossed the right and lower sides of the sampling 
rectangle were included in the count, those that crossed the left and upper sides were 
excluded. 
Kinase Activity Assay for Cdk5 
 
The kinase activity assay was performed according to Glass and Krebs (1982) 
using the Cdk5-specific peptide substrate (Peninsula Labs).  The animals were exposed to 
a light pulse at ZT12 (100 lux, 15 min) and the SCN was rapidly dissected and snap 
frozen in liquid nitrogen and stored at -80°C until further processed.  The SCN tissue was 
sonicated for 10 sec in 50 µl buffer containing glycerophosphate 10 mM and a cocktail of 
protease inhibitors (phenylmethylsulfonyl fluoride (100 µM), phenanthroline (10 mM), 
leupeptin (2 µM), pepstatin (0.2 µM), and aprotinin (1%) (Sigma)), BSA (0.1 mg/ml), 
KT5720 (protein kinase A inhibitor, 0.1 µM), Tris (20 mM), pH 7.4, Mg2+ acetate (20 
mM), and isobutylmethylxanthine (IBMX, 100 µM), and then centrifuged at 2000 × g for 
3 min at 4°C.  A 30 µl aliquot of the supernatant was taken and mixed with 15 µl of 
buffer containing the peptide substrate (400 µg/ml), [γ-32P]ATP (1 µCi/tube), and cold 
ATP (14 µM), and then incubated for 2 min at 37°C. The reaction was stopped by  
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Figure 7: Timeline of light pulse experiment for CK-p25 mice. 
 
Heterozygous CK-p25 mice, 6-8 weeks old, were entrained with 12:12 hr Light:Dark 
cycle. After 2 weeks of entrainment, the mice were released to constant darkness. Mice 
were kept in constant darkness until the end of the experiment. Mice were allowed to 
“free-run” for 10 days after every light pulse treatment. Normal rodent chow was 
replaced with doxycyline based diet for 2 weeks to induce p25 gene expression. To 
repress the gene expression, doxycycline diet was switched to normal rodent chow for 4 
weeks. The experiment was terminated by putting the mice back to Light:Dark cycle. 
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cooling on ice and adding 10 µl of 1N HCl.  A 35 µl aliquot of the reaction product was 
placed on filter paper (Whatman P81 disks) and air-dried.  The filter paper was washed 
with 0.5% orthophosphoric acid until no more radioactivity appeared in the effluent.  The 
dried filter paper was placed in a scintillation vial with 5 ml scintillation fluid and 
counted for 2 min.  Activity is expressed as a percentage of the average difference with 
and without light exposure.  
Calpain Activity Assay 
 
One day before the experiment, C57BL/6 mice, previously stably entrained to a 
12:12 hr L:D cycle were transferred to light proof chambers with the same light cycle, 
housed individually in polypropylene cages with free access to food and water ad libitum. 
Mice were divided into 6 groups – control and experimental groups for each of the three 
circadian time points – ZT16, ZT22 and ZT7. On the day of the experiment, mice were 
given a light pulse (~ 100 lux) for 20 min duration at each circadian time point mentioned 
above. Control mice received no light exposure. Animals were deeply anesthetized 
(ketamine/xylazine, 18/2 mg/kg, i.p) and decapitated with a guillotine. The SCN of 
control animal was collected under dim red-light (less than 5 lux). The brain was 
dissected out and SCN-containing coronal hypothalamic brain sections (500 µm) were 
prepared using a customized tissue slicer. The sections were immediately frozen on to a 
glass slide over dry ice.  A stainless steel needle (400 µm inner diameter) was then used to 
punch out both SCN from each brain section. Cerebellum was also collected from each 
animal. For each experimental condition, SCN and cerebellum from 4 animals were 
collected, and stored at -80°C until use.  The tissue was homogenized in sample buffer 
38 
 
  
(Tris-HCl 20 mM pH 7.5, EDTA 1mM, EGTA 1mM, DTT 1mM). The homogenate was 
centrifuged at 12,000 x g for 10 min and the supernatant was collected. Total protein 
content in the samples was measured using Bio-Rad DC protein assay following 
manufacture’s protocol. Calpain activity was measured using Calpain Glo-Protease Assay 
kit (Promega, Madison, WI) according to the manufacture’s protocol. In this assay, activity 
is measured with luminescence, The luminescence was measured using 20/20n 
luminometer (Turner BioSystems, Sunnyvale, CA). The relative luminescence was 
averaged over 10 sec, background-subtracted, and normalized to the amount of protein in 
the sample. 
Dye-Quenched Fluorescent In-Situ Zymography 
 
One day before the experiment, C57BL/6 mice, previously stably entrained to a 
12:12 hr L:D cycle were transferred to light proof chambers with the same light cycle, 
housed individually in polypropylene cages with free access to food and water ad libitum. 
On the day of the experiment, mice were given a light pulse (~ 100 lux) starting at ZT16. 
At 20 minute intervals, animals were deeply anesthetized (ketamine/xylazine, 18/2 
mg/kg, i.p) and decapitated with a guillotine. The brain was dissected out and post-fixed 
in ethanol:methanol fixative (3:1 by volume) for 6 hr at 4°C. After post-fixation, brains 
were washed in 99% ethanol (4°C) two times 10 min each. It was then trimmed to a 5 
mm block and infiltrated with a mixture of Steedman’s/Polyester wax (Electron 
Microscopy Sciences, Hatfield, PA) with increasing concentrations of the wax (50%, 
75%, 95%, 100%) for 1 hr each in an oven at 37°C. The brain block was left in pure wax 
overnight at 37°C. Finally, the specimens were embedded in 100% polyester wax in flat 
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peel-away tissue embedding containers (VWR, West Chester, PA). Blocks were cut into 
10 µm thick sections using HM340E rotary microtome (Microm, Germany). During 
cutting, the block was cooled by down-draft from dry ice in a funnel positioned 6 inches 
above the cutting block. Ribbon sections obtained were floated in a water bath at 39°C. 
The sections were mounted on Superfrost Plus microscopic slides (Fisher Scientific, 
Pittsburgh, PA) and air dried for 30 min. The sections were then dewaxed briefly in 
graded concentrations of ethanol (50%, 75%, 95%, 100%) for 1 min each. After 
dewaxing, sections were dried overnight at 4°C. The sections were again dewaxed in 
absolute alcohol at 37°C for 5 and 10 min each. The slides were air dried for 10 min 
between each alcohol dewaxing. Following dewaxing, the sections were hydrated in 
graded ethanol (95%, 75%,50%, distilled water) for 3 min each. The in-situ zymography 
protocol was adapted from Gawlak et al. 2009, Fredericks and Mooke, 2004 and Sappino 
et al. 1993. A dye-quenched fluorescent casein substrate, DQ Casein (EnzChek Protease 
Assay Kit, Red fluorescence, Molecular Probes/Invitrogen, Eugene, OR) was used. The 
substrate is heavily labeled with pH-insensitive red-fluorescent BODIPY FL which 
shows an increase in fluorescence once cleaved by the protease. The specimens were pre-
incubated in PBS pH 7.4 at 37°C for 30 min. They were then overlaid with the 
fluorescent substrate, DQ casein diluted 1:100 in 1% low gelling point agarose in PBS 
with 0.9 mM Ca2+ and 1mM Mg2+ and 20 µl of a 4mg/ml solution of purified human 
plasminogen (American Diagnostica, Stamford, CT). 20 µl of the overlay mixture was 
applied to each section, and was spread evenly under 40 x 32 mm glass coverslip. Slides 
were incubated at 37°C in a humidified oven. The incubation was carried out for 3 hr. 
The specificity of protease activity was tested by incubating the sections with an overlay 
40 
 
  
mixture that did not contain plasminogen and one which contained tPA-STOP™. The 
zymograms were observed under a Leica DM4000b epi-fluorescent microscope (Leica, 
Germany). Pictures were taken using DFC 420C cooled CCD camera (Leica, Germany). 
Images were obtained using Leica Application Suite 3.3 (Leica, Germany). The exposure 
settings were 1.5s, gamma=1 and gain=1. For quantitation of fluorescence density, higher 
magnification images (400x) were captured for each SCN. Quantitation was done using 
NIH ImageJ (1.43e, NIH, Bethesda, MD). The images were converted to 8-bit gray-scale 
images (0= black;255=white). To account for background fluorescence, images were also 
captured from the adjacent area of the SCN.  
Gray-scale density correction was done with the following formula (Clemens et 
al., 2005): 
∁ = 255 𝑥𝑥 (𝜎𝜎 −  𝜎𝜎𝑚𝑚𝑚𝑚𝑚𝑚 )(𝜎𝜎𝑚𝑚𝑚𝑚𝑥𝑥 −  𝜎𝜎𝑚𝑚𝑚𝑚𝑚𝑚 ) 
where C = corrected gray-scale density, σ = average of gray-scale values within 
the SCN, σmin = average of gray-scale values in the adjacent SCN region and σmax = 
maximum gray-scale value. 
Data Analysis and Statistics 
 
Statistical analysis was done using the SPSS software (Version 16.0; SPSS Inc., 
Chicago, Illinois). Results are expressed as mean±S.E.M. Paired t-test was used to 
compare two groups. Differences between groups were determined by one way ANOVA 
and Tukey’s HSD post-hoc test where appropriate. p≤0.05 was considered to be 
significant. Graphs were plotted using SigmaPlot (version 11.0; Systat Software, Inc., 
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San Jose, CA). Images were processed with Photoshop CS4 (Abode Systems Inc., San 
Jose, CA). Image analysis was done using NIH ImageJ (version 1.43e; NIH, Bethesda, 
MD).  
 
 
 
  
 
CHAPTER 3 - THE ROLE OF EXTRACELLULAR SERINE PROTEASE 
TISSUE-TYPE PLASMINOGEN ACTIVATOR IN THE MODULATION OF 
NEURONAL PLASTICITY IN CIRCADIAN CLOCK RESETTING 
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Summary 
 
Tissue-type plasminogen activator (tPA) is an extracellular serine protease that 
has been shown to modulate neural plasticity in many brain regions including the 
hippocampus, amygdala and cerebellum.  The present investigation focused on 
identifying the role of tPA in light-induced circadian rhythm resetting in a mouse model.   
Light exposure at night, the time when light is capable of resetting the circadian 
clock, induced transient elevation in the expression of tPA in the mouse SCN.  Not only 
was the expression of tPA in the SCN elevated by light, there was also a corresponding 
increase in the proteolytic activity of tPA in the SCN.  Furthermore, light-induced phase 
delay of the circadian rhythm of mouse wheel running activity was markedly reduced 
after intra-cerebroventricular injection of tPA-STOP™, an inhibitor of tPA. These results 
strongly suggest a potential role for tPA in modulating of light-induced resetting of the 
circadian clock.   
 
  
44 
 
  
Introduction 
 
Circadian rhythm resetting is an important behavioral adaptation to a change in 
environment.  Neuroplasticity often underlies behavioral adaptations to environmental 
changes (Bailey and Kandel, 1993; Schacher and Montarolo, 1991).  Neurotrophins, 
including  nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) 
along with their respective receptors are located within the SCN and have been found to 
modulate photic resetting (Bina and Rusak, 1996; Bina et al., 1997; Liang et al., 2000; 
Michel et al., 2006).  
A mechanical change in synaptic morphology has been hypothesized for the 
acquisition, consolidation and retention of long-term memory (Lamprecht and LeDoux, 
2004).  Inter-cellular membrane interactions, extracellular matrix (ECM), intracellular 
cytoskeleton all contribute to the synaptic cytoarchitecture. Extracellular proteolysis is 
likely to be a major player in the modulation of inter-cellular adhesions (Neuman et al., 
1989; Shiosaka and Yoshida, 2000). The dynamic remodeling requires rapid changes in 
the ECM and receptor signaling (Dityatev and Schachner, 2003).  Extracellular 
proteolytic enzymes, in particular, serine proteases, are likely candidates for the plastic 
remodeling process (Shiosaka, 2004; Shiosaka and Yoshida, 2000; Vassalli et al., 1991).  
Among the serine proteases, tPA has been implicated in numerous aspects of synaptic 
plasticity. 
tPA is a serine protease with a molecular weight of approximately 70kDA. It 
contains domains of kringle, epidermal growth factor, serine protease and fibronectin 
type I (Lunen and Collen, 1993). It was originally identified as a fibrinolytic protease that 
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converted the inactive zymogen, plasminogen into the active protease, plasmin (Lunen 
and Collen, 1993). tPA is released by both neurons and glia (Teesalu et al., 2002; Tsirka, 
2002) and is expressed in many regions of the brain, including the hippocampus, 
amygdala, hypothalamus and cerebellum (Baranes et al., 1998; Pawlak et al., 2003; 
Sappino et al., 1993; Seeds et al., 1995). Overwhelming evidence suggests a role for tPA 
in synaptic plasticity, especially characterized is its effect on hippocampal long-term 
potentiation (LTP).  tPA has been identified as one of the brain activity dependent 
(BAD), immediate-early genes induced in the hippocampal neurons during seizures, 
kindling and LTP (Qian et al., 1993). A previous study suggested that the expression of 
BAD genes were induced in the SCN in response to a light stimulus at night (Kornhauser 
et al., 1992). A more recent study showed that tPA can modulate Glu-induced phase 
shifting in the SCN brain slice (Mou and Prosser, 2006). These observations led us to 
explore the role of tPA in resetting the circadian clock.  
 
 
  
46 
 
  
Results 
 
Light Induces tPA Expression in the SCN 
 
To examine the role of tPA in light entrainment, we investigated whether light can induce 
the expression of tPA in the SCN. Figure 8 describes the expression of tPA following 
light exposure at ZT16. tPA expression in the SCN is rapidly and transiently induced in 
response to light exposure at night. Western blot analysis showed that tPA protein level 
in the SCN started to increase after 40 minutes of light exposure at ZT16, and reached a 
peak level after 60 minutes of light exposure.  The tPA level began to decline after 80 
minutes, and returned to half maximal level after 120 minutes following light exposure. 
The expression was significantly increased following 60 minutes of light exposure. 
 
Light Induces tPA Proteolytic Activity in the SCN 
 
Figure 9 show representative photomicrographs of in-situ zymography for tPA 
proteolytic activity in the SCN. The proteolytic activity was found to be significantly 
increased following 40 minutes of light exposure. The specificity of the reaction was 
tested by omitting plasminogen in the overlay mixture (Figure 9 C) and by adding tPA-
STOP™, an inhibitor of tPA (Figure 9 D). In both the conditions the proteolytic activity 
was found to be decreased. Quantitation of fluorescence show that the proteolytic activity 
increased significantly, showing almost a 2-fold increase following 40 min light exposure 
at ZT16. The specificity of the reaction was tested by incubating with tPA-STOP™. In 
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the presence of the inhibitor, the proteolytic activity was significantly decreased versus 
40 min light exposure (Figure 9 E).  
tPA Modulates Light-induced Phase Shifts in vivo 
 
To determine whether tPA could modulate light-induced phase shift in vivo, we 
monitored the circadian rhythm of mouse wheel running in constant darkness. A 
representative actogram in Figure 10 shows that in tPA-STOP™ infused mice the light-
induced phase delay was significantly reduced (0.3 hrs ± 0.22, n=12) compared to control 
mice that received saline infusion (1.3 ± 0.25 hrs, n=12).  
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Figure 8: Light induces tPA protein expression in the SCN. 
 
A: Representative Western blot showing the expression of tPA after different durations of 
light exposure at ZT16.  B: Bar graph showing fold change in tPA expression levels 
normalized to the control.  tPA expression level was maximally induced 1 hour after light 
exposure. An increase in expression level was first observed at 40 min. The levels started 
to decline after 60 min. An increased expression was seen up to 120 min. following the 
light exposure. Values are presented as mean±S.E.M., n=5 *p<0.05. 
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Figure 9 A-E: Light induces tPA proteolytic activity in the SCN.  
 
The photomicrographs depict dye-quenched fluorescent in-situ zymography for tPA. A ) 
shows the proteolytic activity in the SCN of the control animal (no light exposure).  B) is 
the proteolytic activity in the SCN measured following 40 min of light exposure. The 
specificity of the reaction by tested by omitting plasminogen in the overlay mixture (C) 
by co-incubation with tPA-STOP™ (5µM) (D) F) represents the quantitation of 
fluorescence, a measure of the proteolytic activity. Following 40 min of light exposure, 
the proteolytic activity significantly increased showing almost two-fold increase versus 
control. Incubation with tPA-STOP™ significantly decreased the proteolytic activity. 
Values are mean±S.E.M., n=4 *p<0.05, #p<0.05. Scale bar =100 µm. 
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Figure 10 A-B: tPA-STOP™ attenuates light-induced phase shifts.  
 
(A) A representative double-plotted actogram showing 43 days of activity demonstrates 
that intracerebroventricular injection of tPA-STOP™ into the 3rd ventricle reduces the 
light-induced delay of running activity when compared to the control animals injected 
with saline. The red, blue and green colored lines represent the regression fit lines of 
activity onset after tPA-STOP™ treatment, before tPA-STOP™ treatment and after 
saline treatment (B) The bar graph represents the mean phase delays after injection of 
tPA-STOP™ and following injection of saline. Light-induced phase delay after injection  
of tPA-STOP was decreased (26±8 min.) compared to that following injection of saline 
(90±10 min.). Values are presented as mean±S.E.M n=16 *p<0.05. 
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Discussion 
 
The main goal of this study was to explore the potential role of the extracellular 
protease tPA in the photic resetting of circadian rhythm.  The tPA/plasmin system 
consists of an inactive zymogen, plasminogen that is converted to plasmin, a broad 
spectrum serine protease, by tPA (Collen, 1999). The tPA/plasmin system has been 
implicated in various physiological processes, such as learning and memory in the 
hippocampus, stress responses in the amygdala and motor learning tasks in the 
cerebellum (Madani et al., 1999; Pawlak et al., 2003; Seeds et al., 1995). Several recent 
studies have revealed a critical role of tPA in the maintenance of LTP in the 
hippocampus. A selective reduction of LTP was seen in hippocampal slices from tPA 
deficient mice, suggesting a potential role of tPA in synaptic facilitation (Calabresi et al., 
2000; Frey et al., 1996; Huang et al., 1996). LTP was also shown to be enhanced in 
hippocampal slices from mice overexpressing tPA (Madani et al., 1999). Furthermore, 
mice over expressing tPA showed improved learning capacity (Madani et al., 1999), 
whereas, the mutant mice with a genetic deletion of tPA showed impairment in spatial 
learning tasks (Huang et al., 1996). 
In the first set of experiments, we showed that light could induce transient 
expression of tPA protein in the mouse SCN. An increased expression was seen after 40 
min of light exposure.  The tPA level peaked after one hour and remained elevated for up 
to 2 hours following light exposure. Not only was the expression level of tPA increased, 
there was also a corresponding increase in the proteolytic activity of tPA in the SCN 
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following light exposure as demonstrated in in-situ zymography. A similar light-induced 
expression of polysialic acid and polysialylated neural cell adhesion molecule have been 
observed in the SCN. Polysialylated neural cell adhesion molecule is an important 
mediator of plasticity in cell interactions and has been shown to play a critical role in the 
photic regulation of  circadian rhythm (Glass et al., 2000; Prosser et al., 2003).  Glu-
induced tPA mRNA translation has been demonstrated in hippocampal neurons (Shin et 
al., 2004). In the hippocampus and cerebellum, transcription of tPA mRNA is induced 
after synaptic activation (Amir and Stewart, 1998; Qian et al., 1993; Seeds et al., 2003). It 
has been suggested that there is  an immediate site-specific synthesis and release of tPA 
which is followed by an NMDA receptor mediated upregulation of tPA mRNA (Qian et 
al., 1993; Shin et al., 2004). An analogous mechanism might exist in the SCN. The exact 
mechanism by which tPA expression in the SCN is induced after photic stimulation needs 
to be investigated further. 
The inhibition of light-induced phase delay of circadian wheel running activity by 
tPA-STOP™ suggests that tPA can modulate circadian rhythm resetting. tPA is a broad 
spectrum extracellular protease that converts the inactive zymogen, plasminogen to its 
active form, plasmin, through proteolytic cleavage.  Although the primary substrate of 
tPA is plasminogen, tPA has been shown to mediate the proteolysis of other ECM 
proteins (Hoffman et al., 1998; Nakagami et al., 2000; Wu et al., 2000).  Upon synaptic 
activation in the hippocampus, plasmin converts the immature precursor form of BDNF, 
proBDNF, to its mature form, mBDNF (Pang et al., 2004).  Previous studies have 
demonstrated that BDNF in the SCN could enhance Glu release and potentiate NMDA 
and AMPA mediated currents, through pre-synaptic and post-synaptic mechanisms, 
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respectively (Michel et al., 2006).  Plasmin directly interacts with the NMDA receptor, 
cleaving an amino terminal of the NR2A subunit and augmenting NMDA receptor 
responses (Yuan et al., 2009).  tPA also directly binds to the low-density lipoprotein 
receptor (LRP) independent of its protease activity (Orth et al., 1994).  tPA is rapidly 
endocytosed by LRP after binding to the receptor initiating a series of intracellular 
signaling events (Zhuo et al., 2000). A growing body of evidence suggest that tPA can 
directly cleave the NR1 subunit and thereby increase  Ca2+ influx (Benchenane et al., 
2007; Fernandez-Monreal et al., 2004; Nicole et al., 2001). Thus, tPA has a dual 
influence on the NMDA receptor: an indirect potentiation of Ca2+ influx via LDL 
receptor, and a plasmin mediated enhancement of  NMDA receptor function. tPA may 
modulate photic resetting through one or more of these mechanisms. 
  
 
 
CHAPTER 4 - THE ROLE OF CYCLIN-DEPENDENT KINASE 5 AND ITS 
ACTIVATORS IN CIRCADIAN CLOCK RESETTING BY LIGHT 
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Summary 
 
Cyclin-dependent kinase 5 (Cdk5) is a unique member of the cyclin-dependent 
kinase family that is activated by non-cyclin activators mainly, p35 and p25. Recent 
studies have implicated Cdk5 and its activators in various neurological processes, 
including but not limited to learning and memory, drug addiction and neurodegenerative 
disorders. Cdk5 is a signal transduction molecule downstream to NMDA receptors in the 
Glu pathway.  Since Glu is the principal neurotransmitter of the RHT (Ding et al., 1994), 
we sought to investigate the role of Cdk5 in the light entrainment of the circadian clock.  
SCN neurons expressing the Cdk5 activator, p25 co-localized with 
phosphorylated-extracellular signal-related kinase (p-ERK) and Gastrin Releasing 
Peptide (GRP). Cdk5 activators showed a differential response to light. At ZT16, the 
levels were significantly decreased whereas, at ZT22, it was significantly elevated. At 
ZT6, there was no significant change in the levels. A similar response was seen in the 
activity of Cdk5. The kinase activity was significantly decreased at ZT16, significantly 
increased at ZT22, and unchanged at ZT6. These results were confirmed in a bi-
transgenic mouse model which overexpressed the activator, p25. In the bi-transgenic 
animal, light-induced phase delay in circadian wheel running activity at CT16 was 
significantly increased whereas light-induced phase advance was significantly attenuated. 
Moreover, the bi-transgenic animals exhibited an increased Cdk5 kinase activity in the 
SCN following overexpression of p25, which returned to basal levels once the 
overexpression was repressed. The bi-transgenic animals also demonstrated changes in 
synapse density in the SCN. The synaptic density in the SCN was significantly increased 
following overexpression of p25. Once the overexpression was turned off the synaptic 
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count also returned to basal levels. Taken together, these results strongly suggest that 
Cdk5 along with its activators play a role in the modulation of circadian photic resetting.   
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Introduction 
 
Cdk5 was first discovered in the bovine brain and because it had a sequence homology to 
human CDC2, it was referred to as neuronal CDC2-like kinase (NCLK) (Lew et al., 
1992; Meyerson et al., 1992). Cdk5 is a proline-directed kinase that phosphorylates 
serines and threonines immediately upstream of a proline residue. Like other cyclin-
dependent kinases, Cdk5 by itself has no enzymatic activity. It requires association with a 
regulatory unit for activation. Cdk5 is activated by p35 and p39. It can also be activated 
by p25 and p29, the calpain-mediated cleavage products of p35 and p39. Although, Cdk5 
is expressed in many tissues, the activators are expressed mainly in post-mitotic neurons, 
thus Cdk5 kinase activity is seen highest in the central nervous system (Paglini and 
Caceres, 2001; Paglini et al., 2001). Cdk5 is a pleotropic kinase and more than two dozen 
substrates have been identified (Dhavan and Tsai, 2001; Smith, 2003). 
Cdk5 has been implicated in various neural functions. It is involved in regulation 
of cytoskeletal elements (Hallows et al., 2003; Smith, 2003), axon guidance (Nikolic et 
al., 1996), membrane transport (Barclay et al., 2004; Paglini and Caceres, 2001; Paglini 
et al., 2001; Shea et al., 2004), and synaptic function (Cheng and Ip, 2003). 
In the past few years, Cdk5 has gained more attention for its role in synaptic 
plasticity, learning and memory. A role of Cdk5 in dendritic spine formation has been 
reported in hippocampal neurons (Cheung et al., 2007; Cheung and Ip, 2007). BDNF 
induced dendritic growth was abolished in a TrkB mutant mouse model lacking Cdk5 
phosphorylation site (Cheung et al., 2007). Cdk5 also modulates neuronal secretion at the 
synapse (Cheng and Ip, 2003). Several lines of evidence point to role of Cdk5 in both 
short-term and long-term potentiation. Its role in synaptic plasticity and learning was first 
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studied using the inhibitors, roscovitine and butyrolactone I. The inhibitors suppressed 
LTP induction in hippocampal CA1 area (Li et al., 2001). Long-term depression and 
spatial learning has been shown to be impaired in p35 null mutant mouse model 
(Ohshima et al., 2005). The role of Cdk5 in synaptic plasticity and spatial learning is 
further supported by the observation that transgenic mice that overexpress p25 show 
enhanced LTP and spatial learning (Angelo et al., 2003; Fischer et al., 2005; Ris et al., 
2005). Thus Cdk5 has a multifaceted role in synaptic plasticity. The potential role of 
Cdk5 in light entrainment also stems from the fact that glutamate has been shown to 
induce transient activation of Cdk5 ((Wei et al., 2005). The present study was envisaged 
to investigate the role of Cdk5 in light entrainment by employing the bi-transgenic mice 
that conditionally overexpress the Cdk5 activator, p25. 
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Results 
 
Regional Localization of Cdk5 Activator, p25 in the SCN 
 
Figure 11 A shows the distribution of p25 immunoreactivity in the SCN. p25 positive 
immunoreactivity is seen in both ventro-medial and dorso-medial regions of the SCN, 
more towards the dorsal region. Since the p25 transgene is GFP tagged, it can be 
visualized without immunolabelling. Figure 11 B shows that p25 expressing neurons in 
the SCN co-localize with neurons expressing p-ERK. Figure 11 C shows that p25 
expressing neurons in the SCN are in close approximation to GRP fibers in the “cap” 
region of the SCN.  
 
Effect of Light on Cdk5 and its Activators in the SCN 
 
Figure 12 describes the effect of light on Cdk5 activator levels in the SCN at ZT16, ZT22 
and ZT6. At ZT16 (Figure 12 A) both p35 and p25 levels were decreased (p35- p<0.032, 
p25-p<0.021) compared to control which received no light pulse. At ZT22 (Figure 12 B) 
both p35 and p25 levels were  increased in the SCN following a 20 min light pulse (p35-
p<0.004, p25-p<0.04). At ZT6 (Figure 12 C) there was no  change in p35 or p25 levels in 
the SCN. In contrast to the light exposure at night, light pulse at ZT6 did not induce 
change in p35 or p25 levels in the SCN.  Furthermore, light exposure at night induced 
changes of p25 and p35 levels only in the SCN, but not in the cerebellum.          
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Effect of Light on Cdk5 Kinase Activity in the SCN 
 
The Western blot analysis showed that light exposure at night could induce 
changes in the expression of both p25 and p35 in the SCN.  Figure 13 describes the effect 
of light on Cdk5 kinase activity in the SCN. After a 20 min light pulse (~100 lux), the 
kinase activity was increased at ZT22. The activity decreased at ZT16, whereas, at ZT6 
there was no change in the kinase activity. 
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Figure 11 A-C: Co-localization of Cdk5 activator, p25 in the SCN.  
 
Representative photomicrographs show (A) distribution of neurons expressing p25 
neurons in the SCN. p25-GFP immunoreactivity is seen in the dorsomedial region of the 
SCN (B) p25 expressing neurons are seen to co-localize with p-ERK expressing neurons 
(C) p25 expressing neurons are seen in close approximation to GRP fibers. (Red – pERK 
in 11 B, GRP in 11 C, Green – p25-GFP, white arrows point to co-localization).   
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Figure 12 A-C: Effect of light on Cdk5 activators in the SCN.  
 
A- Cdk5 activator levels in the SCN and Cerebellum at ZT16. B- Cdk5 activator levels in 
the SCN and Cerebellum at ZT22. C- Cdk5 activator levels in the SCN and Cerebellum at 
ZT6. In all the figures upper panel shows representative Western blot bands for Cdk5, 
p25, p35 and GAPDH in the control and light treated group. Lower panel depicts the 
relative densitometric ratio normalized to GAPDH. At ZT16, p35 and p25 levels were 
decreased in the SCN following light exposure. There was no change in the total Cdk5 
level . In the cerebellum, no change was seen in the levels of Cdk5, p35 and p25 after 
light exposure. At ZT22, p35 and p25 levels in the SCN increased following light 
exposure, whereas total Cdk5 in the SCN and p35, p25, Cdk5 levels in the cerebellum 
remain unchanged after the light exposure. At ZT6, there was no change in the levels of 
p35, p25 or Cdk5 in both the SCN and cerebellum. Values are presented as 
mean±S.E.M., n=6, *p<0.05. 
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Figure 13: Effect of light on Cdk5 kinase activity in the SCN.  
 
Cdk5 kinase activity was measured using Cdk5 specific substrate. The average activity of 
the control sample was taken as 1. The kinase activity was measured after light pulse at 
the different circadian time points, ZT16, ZT22, ZT6. The activity measured was 
normalized to basal activity and is expressed as a ratio of the basal activity. Cdk5 kinase 
activity was significantly increased after light pulse at ZT22, at ZT16, the activity was 
significantly reduced, at ZT6 there was no significant change in the kinase activity. 
Values are presented as mean±S.E.M., n=12 *p<0.05, #p<0.05. 
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Figure 14 A-E: Effect of p25 overexpression on light-induced phase shifts in the CK-
p25 mice. 
 
Figure 14 A-E are representative double-plotted actograms of wheel-running activity. 
Each green line represents two consecutive days of activity. Red solid line represents the 
regression fit line of activity onsets of 7 days before the light pulse. Blue solid line 
represents the regression fit line of activity onsets of 7 days (excluding the first two days) 
after the light pulse. Yellow star indicates the time of light pulse. X axis represents time 
in hrs, Y axis represents days. The difference in X axis between the lines on the third day 
after light pulse is the calculated phase shift. Mice were free-running for 10 days before 
the experiment. A 15 min light pulse of 50 lux was given at CT16 (A, B) and CT22 (C, 
D). Subsequent to the light pulse, animals were maintained in DD. p25 overexpression 
was induced by switching the doxycyline based diet to normal rodent chow for 2 weeks. 
Figure 14 E is the quantification of light-induced phase shifts. Values are presented as 
mean±S.E.M. n=12/group. When p25 was overexpressed the phase delay at CT16 was 
significantly increased (No overexpression – -1.28±.0.21 hr, Overexpression -2.27±0.22 
hr, p=0.03). At CT22 the phase advance was significantly attenuated (No overexpression 
– 0.94±0.15 hr, Overexpression – 0.21±0.12 hr, p=0.002). The phase shifts returned to 
basal levels once the overexpression was turned off for 4 wks. 
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Figure 15: Effect of p25 overexpression on Cdk5 kinase activity.  
 
Cdk5 kinase activity was measured using Cdk5 specific substrate. The average activity of 
the control sample was taken as 1 The kinase activity was measured after overexpression 
for 2 wks and 4 weeks after overexpression was turned off . The activity measured was 
normalized to basal activity and is expressed as a ratio of the basal activity. Cdk5 kinase 
activity was significantly increased after p25 overexpression, it returned to basal values 
when expression returned to normal. Values are presented as mean±S.E.M., n=12, 
*p<0.05, #p<0.05. 
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Figure 16 A-C: Effect of p25 overexpression on synaptic density in the SCN.  
 
SCN samples from animals with and without overexpression of p25 were subjected to 
electron microscopic examination for synaptic morphology. A & B are representative 
electron microscopic images. Arrows point to electron-dense post synaptic density(thin 
arrow) and synaptic vesicles (thick arrow). The number of synapses was significantly 
increased following 2 weeks of overexpression of p25 in the CK-p25 mice. The number 
of synapses returned to basal levels once the overexpression was turned off for 4 wks. 
Values are presented as mean±S.E.M., n=12, *p<0.05 Scale bar = 0.5 µm. 
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Discussion 
 
Multiple lines of evidence have implicated Cdk5 in synaptic plasticity, learning 
and memory. The overall objective of this investigation was to identify the role of Cdk5 
in light-induced circadian clock resetting. 
Cdk5 activator, p25 distribution was observed in the dorsomedial and dorsolateral 
regions of the SCN. Co-localization of neurons expressing p25 with p-ERK and GRP was 
also demonstrated. GRP has been considered as the candidate for intra-SCN 
communication of photic input from the retino-recipient calbindinB (CalB) cells found in 
the ventral “core” region of the SCN. Light induces c-Fos and Per1 mRNA in GRP 
expressing neurons in the SCN (Aida et al., 2002; Antle et al., 2005; Earnest et al., 1993; 
Karatsoreos et al., 2006; Kawamoto et al., 2003; Romijn et al., 1996). GRP application 
can produce phase shifts of the circadian clock (Gamble et al., 2007; Kallingal and Mintz, 
2006, 2007; McArthur et al., 2000). GRP induces this phase shift via activation of CREB 
(Gamble et al., 2007). CREB activation is an essential process in light-induced and 
glutamate-induced phase shifts in the SCN (Ding et al., 1997; Tischkau et al., 2003a). 
Furthermore, GRP-induced phase shifts and Per induction requires the MAPK pathway 
(Antle et al., 2005; Moody and Merali, 2004). Our finding that Cdk5 activator p25 co-
localizes with GRP and p-ERK suggests that Cdk5/p25 may be a modulator of this 
pathway. Further studies will be required to elucidate the exact function of Cdk5/p25 in 
this pathway. 
Immunoblot and kinase assay studies demonstrated that light produces a 
differential response in Cdk5 activator levels. The activator levels were decreased at 
ZT16 and increased at ZT22. Consistent with this finding, we found that the kinase 
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activity was decreased at ZT16 whereas, at ZT22 it was increased. A similar finding was 
observed in the light-induced phase shifts of circadian wheel running activity in the bi-
transgenic animal with conditional p25 overexpression. While transient Cdk5 
hyperactivation augmented the phase delaying effect of light at CT16, the phase advance 
at CT22 was attenuated. Taken together, it is apparent that Cdk5 might be modulating the 
integration of photic signaling within the SCN. The only other reported occurrence of 
impairment in phase-advancing photic signaling is in PACAP null mutant mice (Beaule 
et al., 2009; Kawaguchi et al., 2003).  Deficits observed in the PACAP null mutant mice 
has been attributed to impairments in the animal’s ability to integrate stimulus intensity 
and/or duration (Beaule et al., 2009; Nelson and Takahashi, 1991). Considering our 
histological observation that Cdk5 activator co-localizes with cells implicated in intra-
SCN photic signaling pathway, it is a possibility that Cdk5 modulates the sensitivity of 
the circadian system to light. Further studies will be required to test this hypothesis. 
Electron microscopy revealed an increase in the number of synapses in the SCN 
following p25 overexpression. Synaptic morphogenesis is an integral part of neural 
plasticity in other regions of the brain. This is the first report of an alteration of synaptic 
morphology within the SCN. Structural plasticity has been proposed as a mechanism 
involved in light entrainment (Becquet et al., 2008; Bosler et al., 2009; Glass et al., 2003; 
Guldner et al., 1997).  
Collectively, our results indicate a role of Cdk5 in light entrainment, possibly by 
modulating the light sensitivity of SCN and/or altering synaptic morphology. Cdk5 is a 
pleotropic kinase with more than two dozen substrates, it is thus a possibility that both the 
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mechanisms mentioned above or even additional mechanisms are involved in the 
modulation of circadian photic resetting.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
CHAPTER 5 - THE ROLE OF CYSTEINE PROTEASE CALPAIN IN THE 
PHOTIC RESETTING OF CIRCADIAN CLCOK 
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Summary 
 
Calpain is a cysteine protease that is activated by calcium. Calpain has been 
implicated in neuronal processes, including plasticity, learning and memory in the 
hippocampus. Calpain regulates Cdk5 activity by proteolytic cleavage of Cdk5 activators, 
p25 and p35. Studies have indicated that Cdk5 activators also play a role in synaptic 
plasticity, learning and memory. This study was designed to explore the role of calpain in 
circadian photic resetting.  
Calpain-1 immunoreactivity was distributed in the entire SCN from the rostral to 
caudal ends. A denser immunoreactivity was seen in the mid-caudal regions of the SCN. 
Basal expression levels of calpain-1 did not change between the various circadian time 
points, ZT16, ZT22, ZT6. The expression levels also showed no significant change after 
a light pulse at ZT16, ZT22 and ZT6. In contrast to expression levels, basal calpain 
activity levels exhibited a trend, the highest activity was seen at ZT16 and the lowest at 
ZT22. Light induced calpain activity in the SCN. Calpain activity levels were 
significantly increased at ZT16 and ZT22. Light pulse did not produce any significant 
change in calpain activity at ZT6. Our data suggest a potential role for calpain in 
circadian photic resetting but future studies are needed to ascertain the exact role of 
calpain.   
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Introduction 
 
Calpain is a neutral, calcium activated, intracellular cysteine protease expressed both in 
the cytosol and the synaptic terminal in neurons (Mellgren et al., 1989; Pontremoli et al., 
1989; Tomimatsu et al., 2002). There are at least 14 different types of mammalian 
calpains. Two isoforms of calpain are ubiquitously present in the brain: µ-calpain, and m-
calpain (also referred to as calpain I and calpain II, respectively). The other forms of 
calpain are tissue specific and not very well understood (Bevers and Neumar, 2008; Saez 
et al., 2006). Both calpain I and II have similar substrate specificity but differ in their 
sensitivity to Ca2+. Calpain I requires 3-50 µM calcium for activity, whereas calpain II 
requires 0.4-0.8 mM Ca2+ for half-maximal activity (Goll et al., 2003; Mellgren et al., 
1989). Both the calpains contain a subclass-specific 80 kDa catalytic subunit containing 
domains I-IV and a common small 30 kDa regulatory subunit containing domains V and 
VI. Domain II contains the catalytic activity and interacts with substrates and the 
endogenous calpain inhibitor, calpastatin. Calpain undergoes autolytic cleavage on 
domain I (Carafoli and Molinari, 1998; Nakagawa et al., 2001; Ono et al., 1998; 
Sorimachi et al., 1997).  
In the nervous system calpains have been implicated in various neuronal 
functions, including learning, memory and neurotoxicity. Calpain substrates include 
synaptic proteins such as membrane receptors, cytoskeletal proteins, post synaptic density 
proteins and other intracellular mediators of synaptic function (Croall and DeMartino, 
1991; Goll et al., 2003; Guttmann et al., 2001; Lee et al., 2000; Lu et al., 2000). Calpain 
has been implicated in the induction and maintenance of LTP. Inhibition of calpain 
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activity reduces induction of LTP in the hippocampal CA1 area (Oliver et al., 1989; 
Staubli et al., 1988). 
Recent studies have implicated the role of Cdk5 in synaptic plasticity, learning 
and memory (Fischer et al., 2005; Fischer et al., 2002, 2003a; Fischer et al., 2003b; 
Seeburg et al., 2008). Several studies have also indicated a role of Cdk5 activators, p35, 
and p25 in learning and plasticity. p35 homozygous and heterozygous knockout mice 
display impaired contextual fear-conditioned memory (Fischer et al., 2005). p35-
knockout mice also exhibit a lower threshold for theta-burst rhythm-induced LTP (Wei et 
al., 2005). Transient and low-level expression of p25 has been shown to improve 
plasticity and performance in learning tasks in mice that overexpress p25 (Angelo et al., 
2003; Fischer et al., 2005; Fischer et al., 2007). p25 is the calpain mediated proteolytic 
cleavage product formed from p35 (Patrick et al., 1999). Calpain also cleaves the other 
cdk5 activator, p39 to p29 (Patzke and Tsai, 2002). Since circadian photic resetting 
mainly involves the glutamatergic signaling pathway, we hypothesized that the calcium 
activated protease, calpain might play a role in regulating the activity of Cdk5 which in 
turn can modulate light-induced circadian clock resetting. In this study, we sought to 
investigate whether light can induce calpain expression level and or its activity in the 
SCN. 
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Results 
 
Regional Distribution of Calpain in the SCN 
 
Figure 17 A-L show staining for calpain-1 immunoreactivity in the SCN from the rostral 
to caudal ends. Calpain-1 immunoreactivity was observed in the entire SCN at all 
rostrocaudal levels. A denser immunoreactivity for calpain was seen in the mid-caudal 
regions of the SCN.  
 
Effect of Light on Calpain-1 Expression Levels in the SCN 
 
Figure 18 A-C describes the effect of light on calpain-1 expression levels in the SCN. 
Animals were given a 20 min light pulse of 100 lux at circadian time points ZT16, ZT22 
and ZT6. Control animals received no light pulse. There was no significant change in the 
expression levels of calpain-1 in the SCN after light treatment at any of the three 
circadian time points. There was also no significant difference in the basal expression 
level of calpain-1 at the three circadian time points.  
 
Effect of Light on Calpain Activity in the SCN 
 
Figure 19 A & B depict the effect of calpain activity in the SCN. Animals were given a 
20 min light pulse of 100 lux at circadian time points ZT16, ZT22 and ZT6. Control 
animals received no light pulse. Calpain activity was measured using a luminescent based 
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assay. Basal levels of calpain activity showed a trend. The activity was the highest at 
ZT16 and the lowest at ZT6 (A). The activity was significantly increased at both ZT16 
and ZT22 after light treatment (B). 
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Figure 17: Distribution of calpain immunoreactivity in the SCN.  
 
Representative photomicrographs of serial sections from the SCN arranged from the 
rostral to caudal ends. Each section is 30µm thick. Immunoreactivity for Calpain-1 is 
seen in the entire SCN region throughout the rostrocaudal extent. Denser 
immunoreactivity is seen in the mid-caudal sections. OC - optic chiasm, 3V- third 
ventricle. Magnification for all images x100.  
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Figure 18 A-C: Effect of light on calpain expression in the SCN.  
 
Calpain expression levels at (A) ZT16 (B)  ZT22 and (C) ZT6 following a 20 min light 
pulse of 100 lux intensity. Upper panel in all figures are representative Western blot 
bands for calpain-1 and GAPDH. Lower panel bar graphs represent relative densitometric 
ratio of calpain-1 normalized to GAPDH. At all time points, calpain-1 expression did not 
show any change. No change in expression of calpain-1 was observed following light 
exposure at the three points. Values are represented as mean±S.E.M, n=3/group. 
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Figure 19 A-B: Effect of light on calpain activity in the SCN. 
 
Calpain activity was measured using a luminescent assay based on a proluminescent 
calpain substrate. Values are represented as relative light units. A - calpain activity in the 
SCN at circadian time points ZT16, ZT22 and ZT6. B - Calpain activity in the SCN 
following a light pulse at ZT16, ZT22 and ZT6. Basal calpain activity was the greatest at 
ZT16 and the lowest at ZT6. At ZT16 and ZT22 calpain activity increased following light 
exposure. At ZT6 there was no change in calpain activity following light exposure. 
Values are presented as mean±S.E.M., n=3/group, *p<0.05.  
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Discussion 
 
Light-induced phase shifts of the circadian clock are initiated with the release of 
glutamate in the RHT. Glutamate release mainly stimulates NMDA receptors in the SCN 
causing an increased Ca2+ influx that initiates a cascade of intracellular signaling events 
and gene expression ending in phase shift of the circadian clock. Circadian variations in 
the magnitude of NMDA-induced Ca2+ events have been proposed in the SCN neurons 
(Colwell, 2001; Ikeda et al., 2003; Pennartz et al., 2002). Circadian rhythms in cytosolic 
Ca2+ have also been observed in cultured SCN neurons (Ikeda et al., 2003). Ryanodine 
receptors contribute to the amplification of cytosolic Ca2+ via mobilization of Ca2+ from 
internal stores. This Ca2+ induced Ca2+ release has been proposed as the mechanism for 
light-induced phase delays during early subjective night (Ding et al., 1998). Thus, the 
evidence indicates that Ca2+ plays a central role in circadian photic resetting. The goal of 
this study was to explore the role of calpain, a calcium-dependent protease in the photic 
signaling pathway. 
Calpain-1 immunoreactivity was  distributed in the entire SCN. This was the 
expected finding since both calpain-1 and calpain-2 are ubiquitous. The interesting 
finding was that the immunoreactivity was denser in the mid-caudal region of SCN. The 
canonical clock proteins, mPER1 and mPER2 while expressed uniformly in the rostral 
SCN, are concentrated in the shell regions of mid-SCN (Yan and Silver, 2004). It is 
possible that the pattern seen with calpain-1 distribution might be of functional 
significance in circadian photic signaling. 
The basal expression levels of calpain-1 did not show a change at any of the three 
circadian points. Also, no significant change in calpain-1 expression was observed after 
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light pulse treatment. Calpain-1 does not appear to have a circadian expression profile. 
Calpain being a Ca2+ dependent protease, its activity might be regulated by the cytosolic 
Ca2+ rhythms in the SCN. Moreover, the antibody used for Western blotting (Calpain-1, 
domain IV, Abcam, Cambridge, MA) detected both activated and latent forms of calpain. 
This proposed hypothesis is supported by our calpain activity data. We found a trend in 
calpain activity levels in the SCN. The activity was highest at ZT16 and the lowest at 
ZT22. A complete circadian profile of calpain activity will be able to confirm this trend. 
We have demonstrated that light significantly induces calpain activity at both ZT16 and 
ZT22, the time period when SCN is sensitive to light. There was no change in calpain 
activity following the light pulse at ZT6, the time when the SCN is insensitive to light. 
Collectively, our results indicate that calpain might have a role in the modulation of light-
induced phase shifts of circadian clock. The exact mechanism warrants future studies.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
CHAPTER 6 – SUMMARY 
 
It is nearly half a century now, since the phenomenon of light-induced photic 
resetting in mammals was first discovered. In the last 5 decades our understanding of 
circadian rhythms have grown tremendously; many “clock genes”, several signal 
transduction pathways, and presence of “peripheral clocks” have been identified but, the 
enigma of bi-directional response of the circadian clock to light remains unsolved. The 
overall goal of this investigation was to explore the potential role of some known 
modulators of neural plasticity in the light-induced resetting of the circadian clock. To 
achieve this goal the investigation had the following specific aims: (1) Investigate the 
role of extracellular serine protease tPA in the modulation of circadian clock resetting. (2) 
Investigate the role of Cdk5 and its activators in circadian clock resetting. (3) Investigate 
the role of cysteine protease, calpain in the photic resetting of the circadian clock. 
In our first set of experiments (Chapter 3), we demonstrate that light induces the 
expression of tPA in the SCN. The increased expression is associated with a 
corresponding increase in its proteolytic activity. This finding is similar to the one seen in 
the hippocampus where tPA expression was induced in an immediate-early gene fashion 
following stimuli that evoke kindling, seizure or kainic acid injection (Nagai et al., 1999; 
Qian et al., 1993; Salles and Strickland, 2002). The finding is further confirmed in our 
behavioral experiments where we demonstrate that injection of tPA-STOP™, an inhibitor 
of tPA, can attenuate the light-induced phase delay of circadian wheel running activity. 
To our knowledge, this is the first observation to report the role of an extracellular 
protease in circadian photic resetting. 
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The second series of experiments (Chapter 4) tested the hypothesis that Cdk5 and 
its activators modulate light-induced resetting of the circadian clock. We provide 
histological, biochemical, functional and behavioral evidences that prove this hypothesis. 
This is also the first report of the role of Cdk5 in the SCN.  
Thirdly, we provide evidence that the Ca2+ dependent protease, calpain might 
have a role in circadian resetting. 
To summarize, we have identified three new candidates, two proteases and a 
kinase that has a role in modulating circadian photic resetting. We propose a model (Fig. 
20) that integrates the various mechanisms by which these modulators of neuronal 
plasticity might modulation circadian photic resetting. Extracellular serine protease, tPA 
might mediate its action through (1) plasmin mediated interaction of laminin and NMDA 
receptor. (2) tPA can also directly cleave the NR1 subunit of NMDA receptor and 
thereby potentiating  its signaling (3) tPA can also bind to the LRP receptor and after 
being endocytosed potentiate PKA signaling. The cysteine protease, calpain is activated 
following the calcium influx. Activated calpain can cleave the Cdk5 activator, p35 to p25 
which is more stable than p35. Stable p25 produces transient activation of Cdk5 in the 
SCN. Activated Cdk5 might modulate circadian photic resetting by directly interacting 
with NMDA receptor signaling or by modulation of MAPK activity. These are just a few 
suggested mechanisms by which these modulators can integrate circadian photic 
signaling. Additional work will be required to determine the precise cellular signaling 
events that underlie the modulation of circadian photic signaling. 
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Figure 20: Proposed model integrating the modulators of neuronal plasticity in the 
putative photic signal transduction pathway in the SCN.  
Photic signal transduction in the SCN is initiated by the release of glutamate and 
PACAP in the RHT, activating a series of intra-cellular signaling cascades, induction of 
clock genes resulting in phase shifts of the circadian clock. Extracellular serine protease 
tPA might modulate glutamate signaling by (1) plasmin mediated interaction of laminin 
and NMDA receptors (2) directly interacting with NMDA receptors or (3) direct 
interaction with LRP receptors. Calcium influx resultant to NMDA receptor activation 
activates calpain which in turn cleaves the Cdk5 activator, p35 to p25. Stable p25 causes 
transient activation of Cdk5 which might modulate NMDA receptor mediated signaling 
by direct interaction with the NMDA receptors or by modulation of MAPK activity. 
(NOS- Nitric oxide synthase, NO-Nitric Oxide, GC- Guanylyl cyclase, cGMP-cyclic 
GMP, PKG-Protein kinase G, CREB-cAMP response element binding protein, RyR-
ryanodine receptor, AC-Acetyl choline, cAMP-cyclic AMP, PKA-Protein kinase A, 
CaMKII- calmodulin-dependent kinase II, MAPK-Mitogen activated protein kinase, 
LRP-Low-density lipoprotein receptor related protein). 
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Several recent studies have implicated circadian rhythm disturbances associated 
with an increased risk of cancer development, metabolic and cardiovascular disturbances. 
Recently, light therapy has been proposed for some sleep disorders. A better 
understanding of circadian rhythm resetting may lead to the development of new 
treatment modalities.     
Future Studies 
 
To test the proposed model it is necessary to identify the downstream targets of 
both tPA and Cdk5. Recent studies from our lab have in fact identified the presence of 
LRP receptors in the SCN.  Electrophysiological studies employing brain slice 
preparation will help delineate the exact mechanism of action of tPA. Suggested 
mechanisms indicate that Cdk5 can modulate circadian photic signal transduction 
pathways involved in both phase delay and phase advance of the clock. Pharmacological 
modulation of Cdk5 activity as a potential therapy for circadian rhythm disturbances is an 
interesting research idea that needs further exploration. 
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Responsible Conduct of Research 
The ECU Research Ethics Oversight Committee oversees all research compliance 
activities of the University under the direction of the Vice Chancellor for Research, 
Economic Development, and Community Engagement. The committee reviews, 
approves, and resolves conflicts of interest issues and reviews and investigates cases of 
scientific misconduct for individual faculty and the University. A copy of policy 
regarding scientific ethics and misconduct (Part VII section VI of the ECU Faculty 
Manual) is given to each faculty member upon employment. This policy is updated 
regularly on the ECU web site. The University's "Policy and Procedures on Ethics in 
Research and Creative Activity" constitutes institutional efforts to promote responsibility 
by faculty, staff, post doctoral students, and students "to seek honestly and to promulgate 
ethically the truth in all phases of work." The Policy provides, among other things, a list 
of principles to which the University subscribes in its research activities, and procedures 
for reporting, investigating, and determining penalties for unethical research activities 
(Part 7(VI)). 
The Bioethics Center, a joint program of BSOM and PCMH, provides educational 
opportunities for faculty, students, physicians, and hospital staff and supports the efforts 
of hospital committees charged to address ethical issues, including those dealing with 
research. The center sponsors bioethics conferences, workshops, and lectures and is 
staffed by faculty of the Department of Medical Humanities. The University's "Principles 
and Policy for the Protection of Human Subjects of Research” establishes 
"responsibilities for protecting the rights and welfare of individuals who act as subjects 
for research conducted by its [principle investigators]." The Policy provides a Statement 
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of Ethical Principles and implements these Principles through the University Medical 
Center Institutional Review Board (Part 7(1 V)). 
The University and Medical Center Institutional Review Board (UMCIRB) reviews and 
approves of any research, including clinical trials, involving the use of human subjects. 
The board protects the rights and welfare of human subjects engaged in research at 
BSOM, PCMH and its affiliates, and ECU, and in research conducted elsewhere by 
representatives of the University in connection with their responsibilities. 
The University's Policy on "Animal Care and Use in Research and Instruction" becomes 
another instance of institutional efforts to ensure that "animals used in research and 
teaching will receive humane treatment at all times," and to comply fully with applicable 
federal laws and regulations. The Policy provides specific responsibilities required by 
faculty members who conduct or supervise the conduct of animal experimentation. The 
Policy, moreover, establishes the Animal Care and Use Committee with the authority 
formally to monitor the care and use of vertebrate animals (Part 7(V)). 
 
Statement on the Care and Use of Animals in Research 
 
All animal research at East Carolina University meets the requirements and guidelines of 
the NIH Office of Animal Care and Use. The animal facilities at East Carolina University 
are managed under the direction of the Department of Comparative Medicine and are 
AAALAC and IACUC accredited. 
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